CERVICAL CARCINOMA
Clinical trials for CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
HPV-targeting cell therapy tested for advanced cervical cancer
Disease control TerminatedThis early-phase trial tested a new cell therapy called TC-E202 for people with advanced cervical cancer that had stopped responding to standard treatments. The therapy uses a patient's own immune cells, modified to recognize and attack cancer cells infected with HPV type 16. The…
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
Personalized cell therapy shows promise for advanced cervical cancer
Disease control TerminatedThis study tested a new treatment called LN-145 for people with cervical cancer that has come back or spread. The treatment uses a patient's own immune cells (tumor-infiltrating lymphocytes) that are grown in a lab and then given back to fight the cancer. The study aimed to see i…
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC